Investigation of Payloads and Related Impurities in the cysteine-linked Antibody-Drug Conjugate Using Mass Spectrometry Techniques
- 21 July 2026
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (11) , 9241-9257
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Beijing Municipal Science and Technology Commission (Z251100004625003)
- National Key Research and Development Program of China (2023YFC3404004)
- State Key Laboratory of Drug Regulatory Science (2025SKLDRS0336)
- Standardization Improvement Project of Chinese Pharmacopeiae (BZ2025137)
This publication has 20 references indexed in Scilit:
- Influence of antibody–drug conjugate cleavability, drug-to-antibody ratio, and free payload concentration on systemic toxicities: A systematic review and meta-analysisCancer and Metastasis Reviews, 2024
- The journey of antibody-drug conjugates for revolutionizing cancer therapy: A reviewBioorganic & Medicinal Chemistry, 2024
- Intact quantitation of cysteine‐conjugated antibody‐drug conjugates using native mass spectrometryRapid Communications in Mass Spectrometry, 2024
- Quantifying payloads of antibody‒drug conjugates using a postcolumn infused-internal standard strategy with LC‒MSAnalytica Chimica Acta, 2024
- Detection of antibody-conjugate payload in cynomolgus monkey serum by a high throughput capture LC–MS/MS bioanalysis methodJournal of Pharmaceutical and Biomedical Analysis, 2022
- Characterization of Antibody–Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRMAnalytical Chemistry, 2021
- Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugatesJournal of Pharmaceutical Analysis, 2020
- A single liquid chromatography–quadrupole time‐of‐flight mass spectrometric method for the quantification of total antibody, antibody‐conjugated drug and free payload of antibody–drug conjugatesBiomedical Chromatography, 2018
- Advances in antibody–drug conjugates: A new era of targeted cancer therapyDrug Discovery Today, 2017
- Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A ReviewAdvances in Therapy, 2017